NO inhibits cytotoxic T lymphocyte killing of target cells, although the precise mechanism is unknown. We hypothesized that NO decreases exocytosis of cytotoxic granules from activated lymphocytes. We now show that NO inhibits lymphokine-activated killer cell killing of K562 target cells. Exogenous and endogenous NO decreases the release of granzyme B, granzyme A, and perforin: all contents of cytotoxic granules. NO inhibits the signal transduction cascade initiated by cross-linking of the T cell receptor that leads to granule exocytosis. In particular, we found that NO decreases the expression of Ras, a critical signaling component within the exocytic pathway. Ectopic expression of Ras prevents NO inhibition of exocytosis. Our data suggest that Ras mediates NO inhibition of lymphocyte cytotoxicity and emphasize that alterations in the cellular redox state may regulate the exocytic signaling pathway.granzyme ͉ inflammation ͉ lymphocyte ͉ mitogen-activated protein kinases ͉ Ras N O plays a complex set of roles in the immune system (1-4). NO is generated from L-arginine by one of three isoforms of NO synthase (NOS): neuronal NOS (NOS1), endothelial NOS (NOS3), and inducible NOS (iNOS or NOS2) (5, 6). NO can act as an innate immune effector, inhibiting the replication of diverse pathogens such as Mycobacterium tuberculosis, Leishmania, and coxsackievirus (7-12). However, NO and the reactive nitrogen intermediates produced by oxidation of NO can be harmful to the host. For example, NO plays a role in LPS-induced hypotension, LPSinduced lung damage, autoimmune vasculitis, autoimmune encephalomyelitis, autoimmune nephritis, and acute allograft rejection (13-21). Furthermore, NO can suppress inflammation and decrease cell injury. For example, NO inhibits vascular inflammation in part by decreasing endothelial exocytosis of factors that would otherwise promote leukocyte adherence to the vessel wall (22). NO also modulates the immune response, inhibiting T lymphocyte proliferation and differentiation, B lymphocyte proliferation and antibody production, and immune cell production of cytokines (12).NO may also be able to modulate inflammation in part by regulating immune cell killing of target cells. Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells kill infected cells or tumor cells by several distinct pathways, including activation of the Fas͞Fas ligand pathway and exocytosis of cytolytic granules. These cytolytic granules contain perforin, serine proteases (including granzymes), and other effector molecules that promote death of target cells. When a T cell or NK cell recognizes its target, an immunological synapse is formed, a cluster of signaling, adhesion, and cytoskeletal proteins that includes the T cell receptor or a NK cell receptor, tyrosine kinases such as Lck and ZAP-70, and adaptor proteins such as LAT (linker of T cell activation) and . This cluster of signaling molecules activates downstream pathways, including Ras, Raf, MAPK͞ERK kinase (MEK), and ERK. The microtubule organizing center directs the...